Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Melanotan II For Libido: Complete Guide

Melanotan II's effects on libido and sexual function are among its most documented benefits. Learn about the melanocortin mechanism, clinical evidence, and what to expect.

Reviewed by Form Blends Medical Team|Updated March 2026

Melanotan II For Libido: Complete Guide

Quick Answer: Melanotan II for libido is one of its most well-documented effects. By activating MC3R and MC4R in the central nervous system, it stimulates sexual arousal pathways independently of peripheral vascular mechanisms. Clinical trials demonstrated improved erectile function in men and increased sexual desire in both sexes. This effect led directly to the development of bremelanotide (Vyleesi), an FDA-approved sexual dysfunction medication derived from the same melanocortin platform .

How Melanotan II Enhances Libido

Unlike PDE5 inhibitors (Viagra, Cialis) that work by increasing blood flow to genital tissue, Melanotan II acts on the brain. It activates MC3R and MC4R receptors in the hypothalamus and limbic system, the regions that govern sexual desire and arousal .

This central mechanism means Melanotan II affects desire (wanting sex), not just the mechanical ability to perform. This is an important distinction because many people with low libido have adequate blood flow but lack the desire or mental arousal component.

In Men

The first clinical observation of Melanotan II's sexual effects came during early tanning trials when male subjects reported spontaneous erections 1 to 5 hours after injection. Subsequent studies in the International Journal of Impotence Research confirmed that Melanotan II improved erectile function in men with erectile dysfunction, including some who had not responded to PDE5 inhibitors .

In Women

Research showed that melanocortin agonists increased genital arousal and sexual desire in women. This finding ultimately led to the development of bremelanotide (Vyleesi), approved by the FDA in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women .

Clinical Evidence Summary

Melanotan II Sexual Function Evidence
Study/FindingPopulationResult
Phase I tanning trialsHealthy malesSpontaneous erections observed as side effect
Wessells et al., IJIRMen with EDImproved erectile response vs placebo
Diamond et al., UrologyMen with ED73% reported improved erections (vs 27% placebo)
Bremelanotide trials (related)Women with HSDDSignificant improvement in desire and arousal

What to Expect

  • Onset: Sexual effects typically begin 1 to 5 hours after injection
  • Duration: Effects can last 6 to 72 hours after a single dose, varying by individual
  • Both desire and function: Users report increased interest in sex (desire) as well as improved physical response (arousal, erection quality)
  • Dose-dependent: Higher doses produce more pronounced effects but also more side effects (nausea, flushing)
  • Tolerance: Some users report diminishing sexual effects over extended continuous use, supporting the importance of cycling

Melanotan II vs Bremelanotide (Vyleesi)

Melanotan II vs Bremelanotide Comparison
FactorMelanotan IIBremelanotide (Vyleesi)
FDA approvedNoYes (HSDD in women)
Receptor selectivityNon-selective (MC1R-MC5R)MC4R preferring
Tanning effectYesMinimal
AdministrationSubcutaneous injectionSubcutaneous autoinjector
DosingDaily or per protocolAs needed (45 min before)
Nausea incidence50-80%~40%
CostContact provider for current pricingContact provider for current pricing

Important Considerations

  • Priapism risk: In rare cases, prolonged erections lasting more than 4 hours have been reported. This is a medical emergency requiring immediate attention .
  • Not a standalone ED treatment: While Melanotan II can improve erectile function, it is not a substitute for a thorough evaluation of erectile dysfunction causes.
  • Cardiovascular assessment: Sexual activity places cardiovascular demands. Patients with heart conditions should be evaluated before using any sexual enhancement compound.
  • Psychological factors: Low libido often has psychological components (stress, relationship issues, depression) that peptides cannot address alone.

Frequently Asked Questions

How quickly does Melanotan II affect libido?

Most users notice sexual effects within 1 to 5 hours of injection. Some report that the effect builds over several days of consistent use, with a cumulative enhancement in baseline desire.

Does Melanotan II work for women's libido?

Yes. The melanocortin pathway increases sexual desire through central brain mechanisms that operate in both sexes. The FDA approval of bremelanotide (derived from this research) specifically for women's sexual desire disorder validates this mechanism.

Can I use Melanotan II just for sexual benefits?

Some users do, but keep in mind that you will also experience tanning, nausea, and other melanocortin effects. If sexual function is your sole concern, discuss bremelanotide or other targeted options with your physician.

Will the libido effect diminish over time?

Some users report tolerance with continuous daily use. Cycling (using for 4-6 weeks then taking a break) helps maintain the sexual response. See our Melanotan II cycling protocol guide.

Discuss Sexual Health with a Physician

Sexual health is health. At Form Blends, our physicians create confidential, judgment-free treatment plans that address your needs with evidence-based options.

Schedule Your Free Consultation

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Melanotan II is not FDA-approved for any medical condition. Always consult with a licensed healthcare provider before beginning any peptide therapy. Individual results may vary.

Related Articles